Cardiovascular Diseases Sample Clauses

Cardiovascular Diseases. CVDs are the leading cause of death in the U.S. with 2006 prevalence estimates of 81.1 million and mortality of 831,100.17 Prevalence estimates in the U.S. for specific CVDs include: CHD
AutoNDA by SimpleDocs
Cardiovascular Diseases. Heart disease continues to be the leading cause of death on both sides of the U.S.-Mexico border. In 2003, there were 124,932 deaths from heart disease in the U.S. border states, ranging from 3,402 deaths in New Mexico, for a crude rate of 181.5 deaths per 100,000 population, to 68,864 deaths in California, for a crude mortality rate of 194.1 per 100,000 population. The heart disease mortality rate in Arizona was 195.1 and in Texas it was 188.9. In 2003, the mortality rate due to heart disease in the Mexican border states (62.6 deaths per 100,000 population) was higher than the national rate (45.4). The mortality rate ranged from 54.8 (Baja California) to 77.7 (Sonora). For 1992–1994, the mortality rate from heart disease in Mex- ico’s sister cities was about 1.4 times that of Mexico as a whole. Comparisons of rates at the state level with that of the national level showed Baja California’s rate to be 1.4 times greater and Sonora 1.8 times greater than the overall rate for Mexico. The main contribution to heart disease mortality in 2003 was mortality from ischemic heart disease, with crude rates among Mexico’s border states that ranged from Baja California (56.8 per 100,000 population) to Nuevo Xxxx (102.0). In 1992–1994, is- chemic heart disease rates ranged from 49.0 in Coahuila to 67.0 in Sonora.

Related to Cardiovascular Diseases

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Communicable Diseases (a) The Parties to this Agreement share a desire to prevent acquisition and transmission where employees may come into contact with a person and/or possessions of a person with a communicable disease.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • MEDICALLY FRAGILE STUDENTS 1. If a teacher will be providing instructional or other services to a medically fragile student, the teacher or another adult who will be present when the instruction or other services are being provided will be advised of the steps to be taken in the event an emergency arises relating to the student's medical condition.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Communicable Disease Bodily injury" or "property damage" which arises out of the transmission of a communi- cable disease by an "insured";

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

Time is Money Join Law Insider Premium to draft better contracts faster.